Short Reads | GenomeWeb

Short Reads

Premium

In the Myriad versus ACLU court case on the BRCA 1 and BRCA 2 gene patents, the US Court of Appeals for the Federal Circuit ruled that isolated gene sequences are not products of nature, and are therefore patentable. The court also invalidated several of Myriad Genetics' method claims that describe "comparing" and "analyzing" gene sequences.

The National Human Genome Research Institute has named Paul Liu its deputy scientific director. Liu previously led the Oncogenesis and Development Section within NHGRI's Genetics and Molecular Biology Branch.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.